These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Laurent S; Elst LV; Muller RN Contrast Media Mol Imaging; 2006; 1(3):128-37. PubMed ID: 17193689 [TBL] [Abstract][Full Text] [Related]
4. Impact of rigidification on relaxometric properties of a tricyclic tetraazatriacetic gadolinium chelate. Port M; Raynal I; Vander Elst L; Muller RN; Dioury F; Ferroud C; Guy A Contrast Media Mol Imaging; 2006; 1(3):121-7. PubMed ID: 17193688 [TBL] [Abstract][Full Text] [Related]
5. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
7. Design of Gd(III)-based magnetic resonance imaging contrast agents: static and transient zero-field splitting contributions to the electronic relaxation and their impact on relaxivity. Benmelouka M; Borel A; Moriggi L; Helm L; Merbach AE J Phys Chem B; 2007 Feb; 111(4):832-40. PubMed ID: 17249827 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of ZnII-activated magnetic resonance imaging agents. Major JL; Boiteau RM; Meade TJ Inorg Chem; 2008 Nov; 47(22):10788-95. PubMed ID: 18928280 [TBL] [Abstract][Full Text] [Related]
9. Towards understanding the design of dual-modal MR/fluorescent probes to sense zinc ions. Rivas C; Stasiuk GJ; Sae-Heng M; Long NJ Dalton Trans; 2015 Mar; 44(11):4976-85. PubMed ID: 25578943 [TBL] [Abstract][Full Text] [Related]
10. Toward optimized high-relaxivity MRI agents: thermodynamic selectivity of hydroxypyridonate/catecholate ligands. Pierre VC; Melchior M; Doble DM; Raymond KN Inorg Chem; 2004 Dec; 43(26):8520-5. PubMed ID: 15606201 [TBL] [Abstract][Full Text] [Related]
11. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes. Hermann P; Kotek J; Kubícek V; Lukes I Dalton Trans; 2008 Jun; (23):3027-47. PubMed ID: 18521444 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and relaxivity studies of a tetranuclear gadolinium(III) complex of DO3A as a contrast-enhancing agent for MRI. Jebasingh B; Alexander V Inorg Chem; 2005 Dec; 44(25):9434-43. PubMed ID: 16323930 [TBL] [Abstract][Full Text] [Related]
13. Exploiting the Proton Exchange as an Additional Route to Enhance the Relaxivity of Paramagnetic MRI Contrast Agents. Aime S; Baroni S; Delli Castelli D; Brücher E; Fábián I; Serra SC; Fringuello Mingo A; Napolitano R; Lattuada L; Tedoldi F; Baranyai Z Inorg Chem; 2018 May; 57(9):5567-5574. PubMed ID: 29687717 [TBL] [Abstract][Full Text] [Related]
14. Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent. Caravan P; Parigi G; Chasse JM; Cloutier NJ; Ellison JJ; Lauffer RB; Luchinat C; McDermid SA; Spiller M; McMurry TJ Inorg Chem; 2007 Aug; 46(16):6632-9. PubMed ID: 17625839 [TBL] [Abstract][Full Text] [Related]
15. Relaxivity of Gd-Based MRI Contrast Agents in Crosslinked Hyaluronic Acid as a Model for Tissues. Fragai M; Ravera E; Tedoldi F; Luchinat C; Parigi G Chemphyschem; 2019 Sep; 20(17):2204-2209. PubMed ID: 31298452 [TBL] [Abstract][Full Text] [Related]
16. Outer-sphere investigation of MRI relaxation contrast agents. Example of a cyclodecapeptide gadolinium complex with second-sphere water. Bonnet CS; Fries PH; Crouzy S; Delangle P J Phys Chem B; 2010 Jul; 114(26):8770-81. PubMed ID: 20552972 [TBL] [Abstract][Full Text] [Related]
17. Optimization of the relaxivity of MRI contrast agents: effect of poly(ethylene glycol) chains on the water-exchange rates of Gd(III) complexes. Doble DM; Botta M; Wang J; Aime S; Barge A; Raymond KN J Am Chem Soc; 2001 Oct; 123(43):10758-9. PubMed ID: 11674017 [No Abstract] [Full Text] [Related]
18. [Gd-AAZTA]-: a new structural entry for an improved generation of MRI contrast agents. Aime S; Calabi L; Cavallotti C; Gianolio E; Giovenzana GB; Losi P; Maiocchi A; Palmisano G; Sisti M Inorg Chem; 2004 Nov; 43(24):7588-90. PubMed ID: 15554621 [TBL] [Abstract][Full Text] [Related]
19. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field. Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380 [TBL] [Abstract][Full Text] [Related]
20. Contrast material-enhanced visualization of the ablation medium for magnetic resonance-monitored ethanol injection therapy: imaging and safety aspects. Nanz D; Andreisek G; Fröhlich JM; Weishaupt D; Treiber K; Ess S; Pfammatter T J Vasc Interv Radiol; 2006 Jan; 17(1):95-102. PubMed ID: 16415138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]